Imaging brain tumors with ferumoxtran-10, a nanoparticle magnetic resonance contrast agent

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Therapy

• Publication date

  2005-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1586/14750708.2.6.871
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Single-dose contrast agent for intraoperative MR imaging of intrinsic brain tumors by using ferumoxtran-10.

  2005cited by this paper
• An exploratory study of ferumoxtran-10 nanoparticles as a blood-brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions.

  2005cited by this paper
• Imaging, Distribution, and Toxicity of Superparamagnetic Iron Oxide Magnetic Resonance Nanoparticles in the Rat Brain and Intracerebral Tumor

  2005cited by this paper
• Imaging, distribution and toxicity of superparamagnetic iron oxide magnetic resonance agents in rat brain and intracerebral tumor

  2005cited by this paper
• Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours

  2004influential reference
• Blood pool MR angiography of aortic stent-graft endoleak.

  2004cited by this paper
• Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI.

  2004cited by this paper
• Macrophage Imaging in Central Nervous System and in Carotid Atherosclerotic Plaque Using Ultrasmall Superparamagnetic Iron Oxide in Magnetic Resonance Imaging

  2004cited by this paper
• MRI‐based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE

  2003cited by this paper
• Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging.

  2003cited by this paper
• Slowly progressive spread of the stroke-like lesions in MELAS

  2003cited by this paper
• Multimodal magnetic resonance imaging of the central nervous system.

  2003cited by this paper
• The eicosanoid cascade: possible role in gliomas and meningiomas

  2003cited by this paper
• Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents.

  2003cited by this paper
• A pilot investigation of new superparamagnetic iron oxide (ferumoxytol) as a contrast agent for cardiovascular MRI

  2003cited by this paper
• Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study.

  2003cited by this paper
• Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis.

  2003cited by this paper
• Bilateral Demyelinating Tumefactive Lesions in Three Children With Hemiparesis

  2002cited by this paper
• Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors.

  2002cited by this paper
• Symposium I: Brain tumor therapy and pathology Gamma knife radiosurgery for neuroepithelial tumors: Radiological and histological changes

  2001cited by this paper
• Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions.

  2001cited by this paper
• Axonal loss in normal-appearing white matter in a patient with acute MS

  2001cited by this paper
• Limitations of stereotactic biopsy in the initial management of gliomas.

  2001cited by this paper
• Radiosurgery-induced Microvascular Alterations Precede Necrosis of the Brain Neuropil

  2001cited by this paper
• Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model.

  2000cited by this paper
• MR contrast agents in acute experimental cerebral ischemia: Potential adverse impacts on neurologic outcome and infarction size

  2000cited by this paper
• Functional Magnetic Resonance Imaging Using Iron Oxide Particles in Characterizing Head and Neck Adenopathy

  2000cited by this paper
• Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma

  1999cited by this paper
• Multisequence MRI in clinically isolated syndromes and the early development of MS

  1999cited by this paper
• A physiological barrier distal to the anatomic blood-brain barrier in a model of transvascular delivery.

  1999cited by this paper
• In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance

  1999cited by this paper
• Improved delineation of human brain tumors on MR images using a long‐circulating, superparamagnetic iron oxide agent

  1999cited by this paper
• Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography

  1999cited by this paper
• Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis.

  1999cited by this paper
• [Can superparamagnetic contrast media improve MRI-tomographic images of experimental gliomas?].

  1998cited by this paper
• Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION‐46L enhanced in vivo MRI: Early histopathological correlation

  1998cited by this paper
• Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review.

  1998cited by this paper
• Verbessern superparamagnetische Kontrastmittel die MR- tomographische Abgrenzbarkeit experimenteller Gliome?

  1998cited by this paper
• Isolation and characterization of human malignant glioma cells from histologically normal brain.

  1997cited by this paper
• MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent

  1997cited by this paper
• Comparison of dysprosium DTPA BMA and superparamagnetic iron oxide particles as susceptibility contrast agents for perfusion imaging of regional cerebral ischemia in the rat

  1996cited by this paper
• Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions.

  1995cited by this paper
• Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.

  1995cited by this paper
• MR imaging of phagocytosis in experimental gliomas.

  1995cited by this paper
• Potential vascular damage from radiation in the space environment.

  1994cited by this paper
• Phase I clinical evaluation of a new iron oxide MR contrast agent

  1994cited by this paper
• Delivery of virus-sized iron oxide particles to rodent CNS neurons.

  1994cited by this paper
• Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy.

  1991cited by this paper
• Osmotic demyelination syndrome. Lack of pathologic and radiologic imaging correlation.

  1989cited by this paper
• Phase III safety and efficacy study of long-term brinzolamide/timolol fixed combination in Japanese patients with open-angle glaucoma or ocular hypertension

  year unknowncited by this paper

• Magnetic Nanoparticles for Image-Guided Drug Delivery

  2021cites this paper
• Brain Tumor Diagnostics and Therapeutics with Superparamagnetic Ferrite Nanoparticles

  2017cites this paper
• Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside.

  2016cites this paper
• Metal Nanoparticles as Targeted Carriers Circumventing the Blood-Brain Barrier.

  2016cites this paper
• Super-Paramagnetic Nanoparticles with Spinel Structure: A Review of Synthesis and Biomedical Applications

  2015cites this paper
• Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors.

  2015cites this paper
• Imaging Neuroinflammation – from Bench to Bedside

  2014cites this paper
• Recent Advances in Nanotechnology: Potential Prospects in Neuromedicine and Neurosurgery

  2014cites this paper
• Use of Magnetic Nanoparticles in Cancer Detection with MRI

  2014cites this paper
• The Ecotoxicity of Iron Oxide Nanoparticles : Acute, Chronic and Mixture Effects on Daphnia magna

  2014cites this paper
• Uptake and metabolism of iron and iron oxide nanoparticles in brain astrocytes.

  2013cites this paper
• Handling of Iron Oxide and Silver Nanoparticles by Astrocytes

  2013cites this paper
• Visualization of microvascular proliferation as a tumor infiltration structure in rat glioma specimens using the diffraction-enhanced imaging in-plane CT technique

  2012cites this paper
• Enhanced proton treatment in mouse tumors through proton irradiated nanoradiator effects on metallic nanoparticles

  2012cites this paper
• Ferritin up-regulation and transient ROS production in cultured brain astrocytes after loading with iron oxide nanoparticles.

  2012cites this paper
• Nanoparticles for neuroimaging

  2012cites this paper
• Visualizing the future: enhancing neuroimaging with nanotechnology.

  2011cites this paper
• Magnetic Resonance Imaging of Brain Tumors Using Iron Oxide Nanoparticles

  2011cites this paper
• Magnetic nanoparticles and their applications in image-guided drug delivery

  2011cites this paper
• Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?

  2009influential citation
• The role of peptides in blood‐brain barrier nanotechnology

  2008cites this paper
• Effect of heterogeneous vasculature on interstitial transport within a solid tumor.

  2007cites this paper
• Magnetic resonance imaging of human brain macrophage infiltration

  2007cites this paper
• THE POTENTIAL OF FERUMOXYTOL NANOPARTICLE MAGNETIC RESONANCE IMAGING, PERFUSION, AND ANGIOGRAPHY IN CENTRAL NERVOUS SYSTEM MALIGNANCY: A PILOT STUDY

  2007cites this paper
• Recent advances in iron oxide nanocrystal technology for medical imaging.

  2006cites this paper
• Brain cancer diagnosis and therapy with nanoplatforms.

  2006cites this paper
• Blood pool MR angiography of aortic stent-graft endoleak.

  2004cites this paper